We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

Back to rankings

108 hedge funds and large institutions have $261M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 106 → 108 (+2)

6% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 34

9% less capital invested

Capital invested by funds: $287M → $261M (-$26.4M)

47% less call options, than puts

Call options by funds: $7.53M | Put options by funds: $14.2M

Holders
108
Holders Change
+2
Holders Change %
+1.89%
% of All Funds
2.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
36
Reduced
34
Closed
21
Calls
$7.53M
Puts
$14.2M
Net Calls
-$6.7M
Net Calls Change
-$2.89M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$8.29M
2
BC
Broadfin Capital
New York
+$5.8M
3
SHI
SV Health Investors
Massachusetts
+$5.15M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.86M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$4.69M

Top Sellers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
-$6.65M
2
OAM
Oxford Asset Management
United Kingdom
-$4M
3
Axa
Axa
France
-$3.7M
4
State Street
State Street
Massachusetts
-$3.19M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Credit Suisse
Switzerland
$29.6M -$445K -76,627 -1%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$18.8M – – –
BFA
3
BlackRock Fund Advisors
California
$16.3M -$705K -121,467 -4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$15.7M +$1.24M +213,437 +8%
State Street
5
State Street
Massachusetts
$14.9M -$3.19M -549,558 -16%
Goldman Sachs
6
Goldman Sachs
New York
$13.8M -$47.5K -8,178 -0.3%
BC
7
Broadfin Capital
New York
$12.5M +$5.8M +1,000,000 +71%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$12.2M -$1.16M -199,157 -8%
BIT
9
BlackRock Institutional Trust
California
$11.9M +$169K +29,107 +1%
Millennium Management
10
Millennium Management
New York
$11.1M +$8.29M +1,429,350 +204%
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$7.3M +$4.69M +808,536 +136%
GPP
12
Great Point Partners
Connecticut
$6.67M -$304K -52,473 -4%
UBS AM
13
UBS AM
Illinois
$6.62M +$19.1K +3,300 +0.3%
TCP
14
Tourbillon Capital Partners
New York
$6.58M -$1.36M -235,001 -16%
Deutsche Bank
15
Deutsche Bank
Germany
$5.41M +$3.43M +590,863 +131%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$4.89M +$4.86M +837,300 +808%
Northern Trust
17
Northern Trust
Illinois
$4.89M +$171K +29,503 +3%
Group One Trading
18
Group One Trading
Illinois
$4.86M -$1.92M -331,147 -26%
SHI
19
SV Health Investors
Massachusetts
$4.62M +$5.15M +888,132 New
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$3.72M -$2.77M -477,869 -40%
SFM
21
Sphera Funds Management
Israel
$3.56M +$586K +100,911 +17%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$2.78M -$201K -34,612 -6%
Renaissance Technologies
23
Renaissance Technologies
New York
$2.77M +$1.66M +286,860 +117%
TC
24
TFS Capital
Pennsylvania
$2.48M +$2.77M +477,884 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$2.17M +$88.5K +15,255 +4%
1
2 3 4 5

RPTP Hedge Fund Activity: Q4 2015 in Review

108 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2015, worth a combined $261M — down 9.2% from $287M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new RPTP positions and 21 closed out — a net gain of 3 holders — while 36 added to existing stakes and 34 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.29M. The largest seller was Highland Capital Management (Texas), exiting entirely with an estimated $6.65M sold.

  • 108 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2015, up from 106 in Q3 2015.
  • Funds reported $261M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2015, down 9.2% quarter-over-quarter.
  • 24 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2015 and 21 closed out, a net change of +3 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q4 2015 was Millennium Management, an estimated $8.29M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2015 was Highland Capital Management (Texas), an estimated $6.65M sold.

Based on aggregated 13F filings for Q4 2015.